ECM
INFI

Element Capital Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Element Capital Management’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-221,738
Closed -$348K – 107
2017
Q2 		$348K Buy
+221,738
New +$428K 0.07% 61

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Element Capital Management's INFI Position: Q3 2017 in Review

Element Capital Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2017, closing a stake of 221,738 shares — an estimated $348K sold.

Element Capital Management first reported a position in INFI in Q2 2017 and held it in 1 quarter. The position peaked at $348K in Q2 2017. 63 funds tracked by Wall St. Rank hold INFI as of Q3 2017.

  • Element Capital Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2017 after selling out during the quarter.
  • Element Capital Management sold 221,738 Infinity Pharmaceuticals, Inc. shares in Q3 2017, an estimated $348K.
  • Element Capital Management first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2017 and held it in 1 quarter.
  • Element Capital Management's Infinity Pharmaceuticals, Inc. position peaked at $348K in Q2 2017.
  • 63 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2017.

Based on Element Capital Management's 13F filing for Q3 2017, filed 13 Nov 2017.